LIVE

Serial Number

79251096

Owner

PACIFIC PHARMACEUTICALS PTE LTD

Attorney

Sang N. Dang

Filing Date

Oct 3, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ORAMIN-F Trademark

Serial Number: 79251096 • Registration: 5934644

ORAMIN-F is a trademark filed by PACIFIC PHARMACEUTICALS PTE LTD on October 3, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

PACIFIC PHARMACEUTICALS PTE LTD

101 Cecil Street,

Entity Type: 24

Legal Representation

Attorney of Record

Sang N. Dang

280 trademarks filed View all →

Correspondence Address

Sang N. Dang Blue Capital Law Firm, P.C.

650 Town Center Drive, Suite 600

Costa Mesa, CA 92626

United States

Trademark Details

Filing Date

October 3, 2018

Registration Date

December 17, 2019

Published for Opposition

October 1, 2019

Goods & Services

Mineral dietary supplements for humans; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Apr 8, 2026 NA75

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

Apr 8, 2026 C75A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 6, 2026 APRE

TEAS SECTION 71 & 15 RECEIVED

Dec 5, 2025 ES75

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Dec 17, 2024 REM3

FINAL DECISION TRANSACTION PROCESSED BY IB

Apr 17, 2020 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Mar 28, 2020 FICS

FINAL DISPOSITION PROCESSED

Mar 28, 2020 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Mar 17, 2020 FICR

REGISTERED-PRINCIPAL REGISTER

Dec 17, 2019 R.PR

NOTIFICATION PROCESSED BY IB

Oct 5, 2019 GPNX

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 1, 2019 NPUB

PUBLISHED FOR OPPOSITION

Oct 1, 2019 PUBO

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 18, 2019 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Sep 18, 2019 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 11, 2019 NONP

ASSIGNED TO LIE

Aug 29, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 22, 2019 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 21, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 21, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 21, 2019 TROA

REFUSAL PROCESSED BY IB

Mar 16, 2019 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Feb 22, 2019 RFCS

REFUSAL PROCESSED BY MPU

Feb 21, 2019 RFRR

APPLICATION FILING RECEIPT MAILED

Feb 15, 2019 MAFR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Feb 13, 2019 RFCR

NON-FINAL ACTION WRITTEN

Feb 12, 2019 CNRT

ASSIGNED TO EXAMINER

Feb 11, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 11, 2019 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 7, 2019 REPR

Related Trademarks

More from this Owner

CARDIOSPRIN

PACMOL

PHARMAAMERICA

PACMOL

More in Same Class

UNITED EQUINE UE